Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Pharmacia & Upjohn
Approval Status: Approved July 1997
Treatment for: Parkinson's Disease

General Information

Pramipexole was cleared for marketing in the U.S. on July 10, 1997. This is the first new anti-Parkinsonian drug to hit the market in the past six years. Pramipexole can be used to treat all stages of Parkinson's disease. Pramipexole, when given concomitantly with levodopa, improves patients with advanced Parkinson's disease and levodopa-induced motor fluctuation.